Back to jobs
New

Senior/Executive Medical Director, Global Clinical Development

Remote with up to 20% global and domestic travel

Position:          Senior/Executive Medical Director, Global Clinical Development
Department: Translational Science
Location:         Remote with up to 20% global and domestic travel
Reports To:    Senior Vice President, Head of Translational Science

 

Position Summary

Angitia Biopharmaceuticals, a science-driven biotech company dedicated to developing breakthrough therapies for musculoskeletal diseases, is seeking an experienced Senior/Executive Medical Director of Global Clinical Development. This role provides strategic leadership and oversight of global clinical programs and is central to executing our late-stage clinical strategies, with a focus on Phase 2 and Phase 3 development for rare pediatric bone disorders. The ideal candidate will bring deep clinical and scientific expertise in rare pediatric bone disorders, with a strong foundation in endocrinology, and a proven ability to lead pivotal global trials in rare disease settings. Strong leadership experience is essential, including the ability to lead cross-functional teams in a fast-paced, collaborative environment, and effectively represent the company at key scientific engagements.


Responsibilities

  • Provide strategic medical leadership across global clinical development programs in musculoskeletal and skeletal rare diseases, with particular focus on pediatric bone disorders.
  • Lead the design, execution, and oversight of late-stage clinical development programs (Phase 2 and Phase 3), ensuring scientific rigor, patient safety, and regulatory compliance.
  • Design and oversee innovative clinical trial protocols, ensuring alignment with regulatory standards and commercial objectives.
  • Lead cross-functional clinical teams, including medical monitors, clinical operations, biostatistics, and regulatory affairs, to ensure timely and high-quality trial execution.
  • Serve as medical lead for interactions with global regulatory agencies, including strategic planning for regulatory submissions, responses, and key milestone meetings (e.g., End-of-Phase 2, pre-NDA).
  • Provide scientific and clinical input for the development of study protocols, investigator brochures, clinical study reports, scientific publications, and regulatory documents.
  • Maintain strong engagement with Key Opinion Leaders (KOLs) in pediatric bone disease and skeletal endocrinology to support study design and program direction.
  • Represent the company in global forums, including scientific conferences and advisory boards.
  • Actively contribute to the long-term clinical development roadmap and lifecycle management of investigational assets.

 

Qualifications

  • MD or MD/PhD with board certification in endocrinology, pediatric endocrinology, or a related field, with a minimum of 10 years of clinical development experience in the biotech or pharmaceutical industry.
  • Prior success in global trial management and regulatory interactions in the U.S, EU, and other major markets preferred.
  • Proven track record in rare disease clinical development, especially in pediatric bone disorders (e.g., hypophosphatasia, osteogenesis imperfecta, X-linked hypophosphatemia).
  • Successful track record of managing global studies and contributing to regulatory submissions (IND through BLA/NDA).
  • Deep understanding of endocrine mechanisms impacting bone and mineral metabolism.
  • Experience interacting with regulatory authorities on a global scale.
  • Experience leading multidisciplinary clinical teams in a fast-paced, collaborative environment.
  • Proven leadership with strong communication and team-building skills.

 

Salary Range: $240,000 to $280,000

 

About Angitia

Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis (Phase 2), osteogenesis imperfecta (OI) (Phase 1), and spinal fusion (Phase 3). Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization with offices in Westlake Village, CA and Guangzhou, China that is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.

Learn more at www.angitiabio.com.

Benefits:

  • Medical, dental, and vision coverage for employees and their eligible dependents
  • 401(K) Retirement Plan with Company match
  • Company paid Long Term Disability Coverage
  • Company-paid life Insurance & AD&D Coverage
  • Voluntary Life Insurance & AD&D Coverage
  • Employee Assistance Program (EAP)
  • Company-paid Holidays
  • Vacation
  • Paid Sick Leave
  • Telecommunication Monthly Stipend
  • Work-From-Home Equipment Reimbursement

 

Apply for this job

*

indicates a required field

Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf

Education

Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Angitia Incorporated Limited’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.